Taq Wars; The

Summary

Note: Please be aware that the PDF price includes a Enterprise-Wide Electronic License and one print copy.

As the engine that fuels the polymerase chain reaction (PCR)-one of the most important inventions in molecular biology-Taq DNA polymerase has transformed how life science research is conducted. This powerful technique for DNA amplification relies on the amazing processivity of DNA polymerase I enzymes from the bacterium, Thermus aquaticus (Taq DNA polymerase). Because many of its enzymes-including Taq DNA polymerase-are thermostable, it thrives in blistering hot environments. The thermostability of Taq DNA polymerase is the critical feature that facilitated the development of PCR and insured its commercial success.

Since March 28, 2005, researchers no longer need a license to practice the basic PCR amplification process, which was covered by U.S. Patents 4,683,195, 4,683,202 and 4,965,188. This much-anticipated opportunity has opened the door for an influx of suppliers hoping to provide Taq DNA polymerase (without the constraints of a license) to scientists for this specific application. Once Taq DNA polymerase has been incorporated into a scientist's toolbox, it likely remains there for many years, if not for their entire research career. In fact, 33% of respondents have been using Taq polymerase for more than 10 years in their research. Suppliers hoping to secure market share will find The Taq Wars: Competitive Intelligence on How to Survive, a new report produced by BioInformatics, LLC, an indispensable guide to successfully selling this commodity product.

Based on a 28-question survey of researchers who use Taq DNA Polymerase, the report examines what motivates scientists to purchase Taq DNA polymerase from one supplier over another and whether these decisions are influenced by market segment, job position and the length of time scientists have been using the enzyme. It provides insights into whether access to less expensive Taq DNA polymerase will change scientists' purchasing preferences. The report also presents a detailed analysis of price sensitivity and elasticity in regard to the demand for Taq DNA polymerase in three different market segments: industrial, government and academia. By examining the relationship between price and performance, it offers a comprehensive assessment of market expectations, which will allow suppliers to retain their current customer base and acquire new customers.

The report also profiles the top suppliers of Taq DNA Polymerase and what product attributes contribute to their brand's success. It provides critical information as to what factors place suppliers at risk for losing customers to their competitors. By understanding how their products are used, suppliers can better position Taq DNA polymerase to meet their customers' needs. For example, academic scientists spend a greater percentage of their time using Taq DNA polymerase for classic end-point PCR than industrial of governmental scientists. In contrast, industrial scientists spend an increased percentage of their time using Taq DNA polymerase for real-time PCR and sequencing than academic scientists. By examining current and future enzyme consumption rates, the report provides insights into which market segments have the greatest profit potential.

Content